Porcine Immune Milk (Sus scrofa domesticus)

Porcine immune milk contains milk exosomes (MEx) that may modulate immune responses by being internalized by CD14+ monocytes. This colostrum-derived supplement also provides bioactive oligosaccharides and sialic acids that could potentially support immune function.

Origin & History

Porcine immune milk is derived from the milk of domestic pigs (Sus scrofa domesticus), particularly colostrum or early lactation milk rich in immune factors from sows. It is collected from multiparous healthy sows during natural milk ejection, with extraction involving skimming, differential ultracentrifugation (10,000g then 100,000g), and size exclusion chromatography for purifying components like exosomes or oligosaccharides.

Historical & Cultural Context

No historical or traditional medicine uses for porcine immune milk are documented in the available sources. Research emphasizes modern compositional and preclinical analyses rather than ethnomedical context.

Health Benefits

• Potential immune modulation through milk exosomes (MEx) that are internalized by CD14+ monocytes - based only on in vitro porcine cell studies, no human evidence
• May contain bioactive oligosaccharides (OS) and sialic acids (SA) that could support immunity - compositional analysis only, no clinical evidence
• Rich in whey proteins (80-90% of colostrum proteins) - compositional data only, no human health outcomes studied
• Contains extracellular vesicles (MEVs) with stage-specific lipid profiles - preclinical characterization only
• Source of milk-derived exosomes (~100-150 nm particles) - analytical studies only, no human clinical benefits demonstrated

How It Works

Milk exosomes (MEx) from porcine immune milk are internalized by CD14+ monocytes, potentially modulating immune cell signaling pathways. The bioactive oligosaccharides and sialic acids may interact with immune receptors to influence inflammatory responses. These compounds could affect cytokine production and immune cell activation, though the specific molecular pathways remain under investigation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on porcine immune milk were identified in the available research. All studies focus on in vitro porcine cell studies and compositional analyses, such as exosome purification methods (related PMID: 38045600) and oligosaccharide profiling using analytical techniques.

Clinical Summary

Current evidence for porcine immune milk is limited to in vitro studies using porcine cells, with no human clinical trials available. Laboratory studies have demonstrated that milk exosomes can be taken up by CD14+ monocytes in cell culture models. Compositional analyses have identified bioactive oligosaccharides and sialic acids in porcine colostrum. The lack of human studies means efficacy and safety in humans remains unestablished.

Nutritional Profile

Porcine immune milk (colostrum and transitional milk from Sus scrofa domesticus) is compositionally distinct from mature porcine milk. Protein content is exceptionally high in colostrum at approximately 150-200 g/L in early colostrum (0-12 hours post-partum), rapidly declining to 50-80 g/L by 24 hours and ~55 g/L in mature milk. Whey proteins dominate at 80-90% of total colostrum protein, compared to ~20% in mature milk; key fractions include immunoglobulins (IgG ~60-90 mg/mL in early colostrum, IgA ~10-15 mg/mL, IgM ~5-10 mg/mL), lactoferrin (~1-2 mg/mL colostrum), lactoperoxidase, alpha-lactalbumin (~1.5-2.5 mg/mL), and beta-lactoglobulin (~3-4 mg/mL). Casein fraction accounts for ~10-20% of colostrum protein, increasing to ~80% in mature milk. Fat content ranges from 50-90 g/L in colostrum with a fatty acid profile rich in palmitic acid (C16:0, ~26-30% of total fatty acids), oleic acid (C18:1, ~28-32%), linoleic acid (C18:2n-6, ~12-18%), and stearic acid (C18:0, ~10-14%); omega-3 fatty acids (ALA, EPA, DHA) are present at low concentrations (~1-3% of total fatty acids) unless sow diet is supplemented. Lactose is lower in colostrum (~30-35 g/L) compared to mature milk (~50-55 g/L). Bioactive oligosaccharides (OS) are present at approximately 0.3-0.5 g/L in colostrum, structurally similar to but less diverse than human milk oligosaccharides; sialylated OS predominate including 3'-sialyllactose and 6'-sialyllactose. Free sialic acid (N-acetylneuraminic acid, Neu5Ac) is present at ~200-400 mg/L in colostrum. Growth factors include IGF-1 (~150-300 ng/mL colostrum), EGF (~5-20 ng/mL), and TGF-beta (~100-500 ng/mL). Milk exosomes (MEx) are present at ~10^11-10^12 particles/mL, carrying miRNAs, proteins, and lipids. Micronutrients in colostrum include vitamin A (~500-800 µg/L as retinol equivalents, approximately 3-5x mature milk), vitamin E (~5-8 mg/L as alpha-tocopherol, ~3-4x mature milk), vitamin D (~0.3-0.5 µg/L, low), vitamin B12 (~2-4 µg/L), riboflavin (~1-2 mg/L), calcium (~1.5-2.0 g/L), phosphorus (~1.2-1.8 g/L), magnesium (~120-150 mg/L), zinc (~15-25 mg/L in early colostrum, declining sharply), iron (~1-3 mg/L), selenium (~50-100 µg/L). Bioavailability note: porcine colostral immunoglobulins are not absorbed intact across the mature human gut epithelium (gut closure occurs in piglets at ~24-36 hours; analogous passive absorption does not occur in adult humans), meaning immunoglobulin bioactivity in human adults is likely limited to luminal/mucosal effects rather than systemic absorption. Whey protein digestibility is high (~90-95%) and amino acid profile is complete with high branched-chain amino acid content (leucine ~10-11% of protein, isoleucine ~5-6%, valine ~5-6%). Lactoferrin bioavailability is partially preserved due to resistance to gastric proteolysis at physiological concentrations.

Preparation & Dosage

No clinically studied dosage ranges for human use are available as human trials are absent. Studies used analytical quantities such as 7.5 mL skimmed milk for exosome purification or 250 mL milk samples for compositional analysis, without standardization or dosing details for supplementation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bovine colostrum, lactoferrin, immunoglobulins, probiotics, zinc

Safety & Interactions

Safety data for porcine immune milk supplements is extremely limited due to lack of human studies. Individuals with pork allergies should avoid this supplement due to potential cross-reactivity. No known drug interactions have been documented, but caution is advised when combining with immunosuppressive medications. Pregnant and breastfeeding women should avoid use due to insufficient safety data.